DrugPatentWatch Database Preview

ROPINIROLE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Ropinirole Hydrochloride patents expire, and when can generic versions of Ropinirole Hydrochloride launch?

Ropinirole Hydrochloride is a drug marketed by Actavis Elizabeth, Alembic Pharms Ltd, Dr Reddys Labs Ltd, Mylan Pharms Inc, Sandoz Inc, Watson Labs Inc, Wockhardt Ltd, Accord Hlthcare, Alembic Ltd, Apotex, Epic Pharma Llc, G And W Labs Inc, Glenmark Generics, Mylan, Orchid Hlthcare, Prinston Inc, West-ward Pharms Int, Wockhardt, and Zydus Pharms Usa Inc. and is included in nineteen NDAs.

The generic ingredient in ROPINIROLE HYDROCHLORIDE is ropinirole hydrochloride. There are fourteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the ropinirole hydrochloride profile page.

Summary for ROPINIROLE HYDROCHLORIDE

US Patents:	0
Applicants:	19
NDAs:	19
Suppliers / Packagers:	30
Bulk Api Vendors:	96
Clinical Trials:	73
Patent Applications:	1,097
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ROPINIROLE HYDROCHLORIDE
DailyMed Link:	ROPINIROLE HYDROCHLORIDE at DailyMed

Pharmacology for ROPINIROLE HYDROCHLORIDE

Drug Class	Nonergot Dopamine Agonist
Mechanism of Action	Dopamine Agonists

Synonyms for ROPINIROLE HYDROCHLORIDE

1,3-Dihydro-4-(2-(dipropylamino)ethyl)-2H-indol-2-one monohydrochloride

2(H)-Indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-, monohydrochloride

2H-Indol-2-one, 1,3-dihydro-4-(2-(dipropylamino)ethyl)-, monohydrochloride

374R208

4-(2-(Dipropylamino)ethyl)-2-indolinone monohydrochloride

4-(2-(Dipropylamino)ethyl)indolin-2-one hydrochloride

4-(2-(Dipropylamino)ethyl)indolin-2-onehydrochloride

4-(2-di-n-propylaminoethyl)-2(3H)-indolone hydrochloride

4-(2-di-n-propylaminoethyl)-2(3H)indolone hydrochloride

4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one hydrochloride

4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone Hydrochloride

4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride

4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one hydrochloride

4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one;hydrochloride

4-[2-(dipropylamino)ethyl]-2,3-dihydro-1H-indol-2-one hydrochloride

4-[2-(dipropylamino)ethyl]indolin-2-one hydrochloride

4CA-1107

91374-20-8

91374-20-8,91374-21-9(freebase)

91374-21-9 (base)

91374-21-9 (Parent)

A843815

AB0009822

ABP000199

AC-735

AC-736

AC1L2ABS

AC1Q3EQJ

ACT02690

Adartrel

AK-59618

AKOS015844988

AN-15584

ANW-58872

BC207366

BS-1020

CCG-213346

CHEBI:8889

CHEMBL1200411

CS-2864

CTK8B7890

D00784

D7ZD41RZI9

DTXSID50238533

EBD38503

EU-0101101

FC0024

FT-0642200

HP-3000

HY-B0623A

I06-0693

JZP-7

KB-80420

KS-000011L6

KS-00002WRZ

LP01101

LS-83828

M-1298

MCULE-8190476072

MFCD01754173

MLS003899234

MolPort-003-987-439

NCGC00094373-01

NCGC00261786-01

NP-201

NVD-434

R 4152

Repreve

Requip (TN)

ReQuip LP

ReQuip PR

ReQuip XR

Ropinirole (hydrochloride)

Ropinirole for peak identification 1, EuropePharmacopoeia (EP) Reference Standard

Ropinirole for peak identification 2, EuropePharmacopoeia (EP) Reference Standard

Ropinirole HCl

Ropinirole hydrochloride (JAN/USAN)

Ropinirole hydrochloride [USAN:USP]

Ropinirole hydrochloride [USAN]

Ropinirole hydrochloride, EuropePharmacopoeia (EP) Reference Standard

Ropinirole Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur

Ropinirole hydrochloride, powder, >=98% (HPLC)

Ropinirole hydrochloride, United States Pharmacopeia (USP) Reference Standard

Ropinirole hydrochloride;

Ropinirole hydrochloride/

Ropinirolehydrochloride

Ropinirolhydrochloride

s3189

SCHEMBL40760

SK&F 101468-A

SK&F-101468-A

SK&F-101468A

SKF 101468 hydrochloride

SKF 101468; 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride

SKF-101468A

SMR001456484

SR-01000076215

SR-01000076215-2

ST24042825

ST51051236

TC-030791

TL8005858

Tox21_501101

UNII-D7ZD41RZI9

XDXHAEQXIBQUEZ-UHFFFAOYSA-N

Z1695926158

US Patents and Regulatory Information for ROPINIROLE HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glenmark Generics	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET;ORAL	090135-001	Feb 25, 2010	AB	RX	No	No
West-ward Pharms Int	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET;ORAL	077852-002	May 5, 2008	AB	RX	No	No
Accord Hlthcare	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET;ORAL	204022-005	Feb 28, 2017	AB	RX	No	No
Wockhardt Ltd	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET, EXTENDED RELEASE;ORAL	091395-001	Aug 27, 2012	AB	RX	No	No
Orchid Hlthcare	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET;ORAL	079229-001	Nov 28, 2012	AB	RX	No	No
Zydus Pharms Usa Inc	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET;ORAL	090411-001	Jun 1, 2009	AB	RX	No	No